Eudaimonia Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Eudaimonia Partners, LLC

  • $416 Million
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$472.8 - $558.54 $9,456 - $11,170
-20 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$446.73 - $548.2 $8,934 - $10,964
20 New
20 $9,000
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $38,972 - $50,869
-79 Closed
0 $0
Q1 2020

May 05, 2020
BUY
$336.18 - $494.43 $26,558 - $39,059
79 New
79 $39,000

Others Institutions Holding REGN

# of Institutions
1,531
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $79.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Eudaimonia Partners, LLC Portfolio

Follow Eudaimonia Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eudaimonia Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eudaimonia Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email